Catasys, Inc. (OQ:CATS)

Business Focus: Healthcare Facilities & Services

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CATS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 10/20 Feb 6/20 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -796 $18.84
Feb 7/20 Feb 5/20 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -25,256 $18.80
Feb 14/20 Jan 22/20 Medeiros Curtis Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 25,724  
Dec 18/19 Dec 16/19 Shirley Christopher Direct Ownership Stock Option to purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 65,000  
Feb 14/20 Dec 2/19 Medeiros Curtis Direct Ownership Stock Option to purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 300,000  
Dec 18/19 Jul 16/19 Rebak Robert Direct Ownership Stock Option to purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 85,551  
May 16/19 May 15/19 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -42,229 $18.45
May 15/19 May 14/19 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -10,000 $18.27
May 15/19 May 13/19 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -24,500 $18.14
May 10/19 May 10/19 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -500 $18.24
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CATS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Dec 2/19 Medeiros Curtis Direct Ownership Stock Option to purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 300,000  
Feb 14/20 Jan 22/20 Medeiros Curtis Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 25,724  
Feb 10/20 Feb 6/20 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -796 $18.84
Feb 7/20 Feb 5/20 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -25,256 $18.80
Dec 18/19 Dec 16/19 Shirley Christopher Direct Ownership Stock Option to purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 65,000  
Dec 18/19 Jul 16/19 Rebak Robert Direct Ownership Stock Option to purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 85,551  
May 16/19 May 15/19 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -42,229 $18.45
May 15/19 May 14/19 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -10,000 $18.27
May 15/19 May 13/19 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -24,500 $18.14
May 10/19 May 10/19 Smith David E Indirect Ownership Common Stock, par value $0.0001 per share S - Open market or private sale -500 $18.24
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CATS

Competitors

Competitors with Recent Insider Filings
CVS Health (N:CVS)
Quest Diagnostics (N:DGX)
Chemed (N:CHE)